Telomir Pharmaceuticals to Participate in BIO 2025 in Boston as Company Prepares for IND Submission and Advances Breakthrough Longevity Platform
MIAMI, FL / ACCESS Newswire / June 2, 2025 / Telomir Pharmaceuticals, Inc. (Nasdaq:TELO) ('Telomir' or the 'Company'), an emerging leader in age-reversal science, today announced its participation in the BIO International Convention 2025, taking place in Boston, MA from June 16-19, 2025. The Company has scheduled a full week of BIO One-on-One Partnering™ meetings to explore strategic collaborations, licensing opportunities, and potential M&A transactions.
Telomir is actively preparing to submit an Investigational New Drug (IND) application by the end of this year for its lead candidate, Telomir-1-a novel small molecule designed to elongate telomeres, regenerate cells, and reverse core mechanisms of biological aging. The Company is gearing up for its pre-IND meeting with the FDA, with the goal of initiating first-in-human dosing in the first half of 2026.
As part of its expanding pipeline, Telomir is advancing a rare-disease exploratory and developmental strategy focused on high-need orphan indications where cellular aging plays a central role. These include:
The Company plans to meet with the FDA to establish novel clinical endpoints across its rare disease programs, aiming to unlock accelerated development pathways and regulatory flexibility.
In parallel, Telomir-1 is also being investigated in autism spectrum disorder, where its potential impact on telomere biology, oxidative stress, neurodegeneration and inflammation may offer a novel therapeutic approach for neurodevelopmental conditions.
Beyond rare and neurological disorders, Telomir has achieved significant preclinical success across a range of high-impact therapeutic areas, underscoring the versatility of its platform:
'The breadth of our preclinical data showcases the potential of Telomir-1 not just as a treatment-but as a platform for addressing aging-related and rare diseases at the source,' said Erez Aminov, Chief Executive Officer of Telomir. 'As we prepare for IND submission and for a pre-IND meeting with the FDA, we look forward to connecting with potential partners at BIO to explore licensing and M&A opportunities that can help accelerate our path to the clinic.'
Dr. Angel, Chief Scientific Advisor at Telomir, added:
'In all my years in drug development, I've never seen a molecule with this kind of cross-indication potential. The science behind Telomir-1 is remarkable-it's addressing cellular aging at its root, and the preclinical data speak for themselves. What excites me most is how this one molecule may have the power to transform how we treat aging-related, metabolic, and rare genetic diseases across the board.'
Cautionary Note Regarding Forward-Looking Statements
This press release, statements of Telomir's management or advisors related thereto, and the statements contained in the news story linked in this release contain 'forward-looking statements,' which are statements other than historical facts made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These risks and uncertainties include, but are not limited to, the potential use of the data from our studies, our ability to develop and commercialize Telomir-1 for specific indications, and the safety of Telomir-1.
Any forward-looking statements in this press release are based on Telomir's current expectations, estimates and projections only as of the date of this release. These risks and uncertainties include, but are not limited to, the potential use of the data from our studies, our ability to develop and commercialize Telomir-1 for specific indications and safety of Telomir-1. These and other risks concerning Telomir's programs and operations are described in additional detail in its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which is on file with the SEC. Telomir explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.
Contact Information
Helga Moya
[email protected]
(786) 396-6723
SOURCE: Telomir Pharmaceuticals, Inc
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Epoch Times
37 minutes ago
- Epoch Times
Taiwanese Doctor Expresses Concern Over China's Organ Industry
A Taiwanese doctor who is part of a medical ethics nonprofit has expressed concerns about China's organ industry, especially regarding children. Huang Shiwei, vice chairman of the medical ethics nonprofit Taiwan International Organ Transplant Care Association, told NTD's Health 1+1 program that he was troubled by an alleged order that a hospital gave medical student Luo Shuaiyu. The medical student, Luo Shuaiyu, specialized in kidney transplantation at the Second Xiangya Hospital of Central South University. Authorities said Luo fell to his death from a building in May 2024, just weeks before his graduation. According to audio recordings released by his parents after his death, Luo had been asked to locate 12 child donors aged 3 to 9, ostensibly for medical purposes. Huang said this is concerning given China's record of forced organ harvesting. 'They asked [Luo] to find child donors. Where was he supposed to look?' Huang said. Pediatric Organs On May 21, 2024, Fudan University Medical College in Shanghai established a pediatric organ transplant center. According to the university, Li Qian, the Chinese Communist Party (CCP) secretary at the pediatric hospital, said that 'in just over a year, [pediatric organ transplants] have exceeded 100 cases.' State media outlet Sina reported that the hospital has performed highly complex surgeries, including kidney transplants from donors weighing less than 5 kg (11 pounds), indicating that newborns are among the donors. In 2017, the First Affiliated Hospital of Sun Yat-sen University in Guangzhou reported that 90 percent of pediatric kidney donors were allocated to adult patients. A 2023 study by doctors from Shanghai Jiao Tong University's Renji Hospital, published in the American Journal of Transplantation, detailed two cases of kidney transplants from newborns born at 29 weeks and 29 weeks, 5 days to adult women aged 34 and 25 with end-stage kidney disease. The kidneys were harvested on the second and third days after birth, prompting ethical scrutiny. Shabih Manzar, associate professor of clinical pediatrics at Louisiana State University, questioned the procedure in the same journal, noting that one of the 29-week preterm infants had no apparent life-threatening conditions, casting doubt on the decision to withdraw life-sustaining treatment. Huang noted the high survival rates of 29-week preterm infants with modern medical technology. 'Whether it's the parents or the medical system, everyone would typically do everything possible to save these preterm newborns,' he said. 'No one would give up and simply designate them as organ donors. Yet, we see that they are using 29-week preterm infants as organ donors.' China's Organ Harvesting Industry China began using organs from executed prisoners following a 1984 regulation allowing the practice. After 1999, when the regime began persecuting the spiritual group Falun Gong, China's organ transplant industry exponentially increased. Huang noted that when former CCP leader Jiang Zemin initiated the persecution campaign against Falun Gong, practitioners were branded as 'class enemies,' making them prime targets for forced organ harvesting. This period marked an unprecedented surge in organ transplants. According to data from the World Organization to Investigate the Persecution of Falun Gong, compiled from Chinese state media reports, only 135 liver transplants were recorded in China over more than two decades before 1999, averaging five to six cases annually. From 1999 to 2006, liver transplants skyrocketed to 14,085 cases over the eight-year period, averaging more than 1,700 cases per year—a 180-fold increase. 'Organ transplantation in China suddenly became a massive industry,' Huang said. 'With countless patients in China and worldwide needing organs, there are enormous commercial interests at play.' In March 2006, a whistleblower using the pseudonym Annie, a former employee of Sujiatun Thrombosis Hospital in Shenyang, Liaoning Province, revealed to The Epoch Times the CCP's horrific practice of forced organ harvesting from Falun Gong practitioners. This exposure had a significant impact on China's organ transplant industry. According to the China Liver Transplant Registry, cited by state media People's Daily, liver transplants peaked at 2,970 cases in 2005 and 2,781 in 2006 but fell by roughly one-third to 1,822 cases in 2007. Huang attributed this decline to the 2006 revelations. 'The reason for the decrease in organ transplants in China in 2007 was the exposure of the CCP's forced organ harvesting from Falun Gong practitioners,' Huang said. 'As relatives relentlessly searched for family members detained for practicing Falun Gong, it became increasingly difficult for the CCP's public security and medical personnel to continue using Falun Gong practitioners' organs on such a large scale.' He said the drop in transplant numbers underscores the international scrutiny and domestic pressure that began to disrupt the CCP's organ harvesting operations. Concerns 'Forced organ harvesting in China appears to be targeting specific ethnic, linguistic, or religious minorities held in detention, often without being explained the reasons for arrest or given arrest warrants, at different locations,' according to a 2021 joint statement from the U.N. Office of the High Commissioner for Human Rights. Huang said: 'In most countries, organ donors tend to be older, 50, 60, or even 70 years old. But in China, the organ transplant industry operates differently. When organs are supplied to wealthy individuals, they naturally demand those from younger people.' Huang said he believes in China there is now an increasing focus on obtaining organs from young individuals, including children. A surge in mysterious disappearances of adolescents across multiple Chinese provinces in recent years has fueled public suspicion of organ trafficking, especially because of China's extensive surveillance infrastructure. In October 2022, Hu Xinyu, a first-year high school student in eastern China's Jiangxi Province, mysteriously disappeared from school. Various reports from insiders and overseas whistleblowers allege that the Hu case is linked to forced organ harvesting. In August 2023, 8-year-old Wang Sijun, who had a rare Rh-negative blood type, died unexpectedly while receiving treatment at Yunnan Red Cross Hospital. According to viral videos posted by her family on platforms such as Douyin, Wang was admitted for a routine examination while accompanying a relative, only to die in the nephrology ward. Her autopsy cited hemorrhagic shock as the cause of death, with traces of the anticoagulant enoxaparin sodium detected, leading her family to suspect blood extraction and organ theft. Although no definitive evidence confirms organ harvesting in the case, Huang noted that widespread allegations of hospitals engaging in such practices have created a climate of heightened anxiety. Documented cases, such as a fraudulent organ donation scandal in Anhui Province's Bengbu City, lend credence to these concerns. Between 2017 and 2018, six defendants, including four doctors, were convicted of deceiving families and illegally harvesting organs from at least 11 patients. 'China's organ transplant industry, driven by the Communist Party's ideology, has evolved into a vast commercial enterprise,' Huang said. 'These cases show it has become an unregulated beast, with rampant, unchecked organ harvesting.'
Yahoo
an hour ago
- Yahoo
Collagen Supplement Trends in 2025: Why Pilly Labs Collagen Gummies Are Leading the Natural Glow-Up Movement
As consumer demand for clean beauty and functional supplements rises in 2025, marine collagen gummies like Pilly Labs are emerging as a preferred daily solution for supporting skin texture, joint mobility, and hair strength — all without powders, pills, or synthetic additives. New York, Aug. 02, 2025 (GLOBE NEWSWIRE) -- This press release is for informational purposes only. The information contained herein does not constitute medical advice, diagnosis, or treatment and has not been evaluated by the Food and Drug Administration (FDA). Collagen Supplement is not intended to diagnose, treat, cure, or prevent any disease. Always consult your physician or qualified healthcare provider before beginning any new supplement, routine, or health program. Some links in this release may be promotional in nature and may lead to third-party websites. The publisher or author may receive compensation through affiliate commissions if a purchase is made through these links. This compensation does not affect the price you pay and helps support continued research and content publication. Results described or implied may not be typical and should not be interpreted as guarantees. Statements made about ingredients or outcomes reflect public discussion and historical usage only, and are not endorsed by medical professionals or regulatory agencies. Always do your own research and make informed decisions. Collagen Supplement Trends in 2025: Why Pilly Labs Collagen Gummies Are Leading the Natural Glow-Up Movement As more people turn to natural solutions for skin, joint, and hair support, collagen supplements have become a top trend in wellness for 2025. Pilly Labs Collagen Gummies, a marine-based collagen supplement enhanced with Vitamin C, Biotin, and Zinc, are rapidly gaining attention for their clean-label design and long-term beauty support. With consumer interest in inside-out health and sustainable self-care at an all-time high, this functional formula offers a delicious and effective way to build a glow-up routine that fits today's wellness demands. From skincare influencers to wellness podcasts and TikTok self-care trends, the spotlight on collagen supplementation has never been brighter. As consumers seek more natural, effective ways to support their skin's elasticity, joint mobility, and hair strength, collagen has emerged as a foundational nutrient in the 2025 health and beauty landscape. But not all collagen products are created equal — and that's where Pilly Labs Collagen Gummies are beginning to stand out. This new wave of clean, marine-sourced collagen supplements is redefining how modern consumers approach beauty from within. Ready to support glowing skin, strong hair, and resilient joints from the inside out?Explore the Full Pilly Labs Collagen Supplement Formula Today Why Interest in Collagen Supplement Is Surging in 2025 Collagen supplements have exploded across TikTok, Google search, and wellness podcasts in 2025 — driven by rising demand for skin-plumping nutrients, joint resilience, and visible glow-up routines that feel both natural and effective. Monthly search volume for 'collagen supplement' has surged past 400,000 in the U.S. alone, fueled by Gen Z and Millennial audiences looking for non-invasive ways to support aging, mobility, and beauty from within. On TikTok, creators are documenting 30-day collagen challenges, while Reddit users are compiling ingredient spreadsheets comparing marine peptides, hydrolyzed formulas, and absorption-enhancing stacks. The term 'collagen routine' now appears in skincare, gut health, and even fitness hashtags, revealing how mainstream this once-niche supplement category has become. What makes 2025 different? Consumers are no longer just buying products based on claims — they're researching clinical studies, comparing formulations, and tracking their personal results over 3-, 6-, and 12-month use periods. That's why long-term, habit-forming delivery formats like collagen gummies are growing rapidly compared to powders or pills. The shift is also linked to what trend analysts call 'beauty rationalism' — the belief that if your body can rebuild its own structures from the inside, you'll age better naturally. And in that framework, collagen isn't hype — it's a foundational building block. Collagen Supplement's Ingredient-First Response to These Trends As public demand for long-term wellness routines grows, a new generation of supplement users is prioritizing clean sourcing, formulation transparency, and ingredient synergy. Pilly Labs Collagen Gummies meet that demand head-on — not through hype or aggressive marketing, but through an ingredient-first design philosophy that aligns with the modern consumer's standards for internal beauty support. At the core of the formula is hydrolyzed marine collagen — a highly bioavailable peptide source derived from wild-caught fish like tilapia and cod. Marine collagen is frequently explored in collagen research circles for its smaller molecular weight, which may aid digestion and uptake compared to bovine or porcine sources. Pilly Labs chose this collagen type specifically for its solubility, sustainability, and wide acceptance in clean-label beauty stacks. But collagen alone isn't enough. That's why the formula incorporates supportive nutrients like Vitamin C (ascorbic acid), Biotin (D-Biotin), Zinc (from citrate), and Vitamin E — each frequently discussed for their role in structural skin protein formation, hair integrity, and cellular repair. These additions position the formula within the broader trend of 'co-factor supported supplementation,' a movement where each ingredient amplifies the others through intelligent synergy. The delivery format itself also plays a key role. Unlike messy powders or oversized capsules, Pilly Labs uses a fruit-flavored gummy that's easy to take daily — a decision made to improve user compliance over the full 90-day to 6-month collagen renewal cycle. This convenience-forward format is backed by a growing body of user behavior data showing that daily habit consistency is a major predictor of visible results. Finally, the formula avoids additives that many wellness-savvy buyers now actively exclude. Pilly Labs Collagen Gummies are gluten-free, non-GMO, antibiotic-free, and made without artificial sweeteners or dyes. Even the coloring is derived from natural purple carrot concentrate — another nod to the brand's clean beauty alignment. Curious how marine collagen, Biotin, and Vitamin C work together for long-term beauty support?See the Full Breakdown of Pilly Labs Collagen Gummies Here Ingredient Spotlight – What's Inside the Formula Understanding what's inside a collagen supplement is just as important as knowing why to take one. Pilly Labs Collagen Gummies were formulated with a clear goal: to reflect the most talked-about, synergistic nutrients in the world of beauty-from-within, without relying on synthetic additives or filler ingredients. The core of the formula is hydrolyzed collagen peptides — marine-derived proteins that are frequently associated with skin elasticity, hair structure, and joint cushioning in wellness routines. Unlike raw collagen, hydrolyzed peptides are smaller in molecular weight, which is why they are often explored for improved absorption in digestive and skin health regimens. To enhance this collagen foundation, Pilly Labs includes Vitamin C (Ascorbic Acid) — a well-known antioxidant that is commonly referenced in research on collagen synthesis. Vitamin C helps support the body's natural process of turning collagen peptides into usable structural proteins, making it one of the most essential co-nutrients in any beauty formula. Also featured is Biotin (D-Biotin) — a B-complex vitamin frequently discussed in hair, skin, and nail support communities. Biotin plays a role in keratin production and is a popular inclusion in wellness stacks focused on hair thickness and nail strength. The formula also provides Zinc (from Zinc Citrate) — a trace mineral that has been explored for its relevance to tissue repair and barrier function. In holistic supplementation circles, zinc is often combined with collagen to support overall skin integrity. Vitamin E (as DL-Alpha-Tocopheryl Acetate) rounds out the antioxidant support, helping protect cells from oxidative stress — a common factor in visible aging and structural protein breakdown. Other supportive elements include Glycine (a primary amino acid in collagen itself), natural fruit-based sweeteners like purple carrot juice concentrate, and a plant-based gummy matrix using pectin and coconut oil instead of gelatin or synthetic binders. By combining these elements into a single, clean-label delivery system, Pilly Labs positions its collagen supplement at the intersection of science-backed structure and modern ingredient transparency — key factors in today's high-trust wellness economy. What Reddit, Podcasts & TikTok Creators Are Saying In 2025, social platforms like TikTok, Reddit, and Spotify-hosted wellness podcasts have become central hubs for everyday users to explore supplements, routines, and health experiments. Among them, collagen supplementation — especially in gummy form — continues to trend as one of the most discussed daily rituals in beauty and longevity communities. On TikTok, creators are showcasing their 30-, 60-, and 90-day glow-up challenges using collagen, often in 'before and after' style videos documenting changes in skin texture, hair bounce, and morning mobility. Hashtags like #collagengummies, #marinecollagen, and #skinglowup2025 are attracting millions of views, with users comparing brands based on ingredient transparency and how easy the format is to stick with. Reddit threads across r/Supplements, r/SkincareAddiction, and r/Healthygamergg have seen growing curiosity around how marine collagen differs from bovine-based formulas, whether gummies are as effective as powders, and what real users are experiencing after three months of daily use. The tone is rarely prescriptive — instead, it's marked by personal testing, ingredient breakdowns, and crowdsourced feedback loops. Meanwhile, in the podcast space, wellness influencers and holistic nutritionists are dedicating full episodes to 'collagen stacking,' where listeners explore how nutrients like Biotin and Vitamin C work in synergy with peptides. Marine collagen often gets attention for its sustainability angle and smaller molecular structure, while gummies continue to be praised for compliance and taste. Across all platforms, the most common thread is not hype — it's habit. Content creators consistently focus on what's easy to maintain over months, not just what works for a few days. That's part of why products like Pilly Labs Collagen Gummies — with their clean label, taste-first design, and non-disruptive format — fit into the routines people are already building around skincare, nutrition, and long-term vitality. Looking for a collagen supplement that's clean, effective, and easy to take every day?Discover Why Pilly Labs Collagen Gummies Are Leading in 2025 Who Might Be Drawn to This Type of Supplementation in 2025 The rise of collagen supplementation in 2025 is being driven not by any single demographic, but by a wide spectrum of lifestyle mindsets — each with its own reasons for embracing daily nutrient routines. Pilly Labs Collagen Gummies are not positioned for one type of consumer, but rather align with the habits, values, and routines of individuals seeking long-term, structural wellness support. Biohackers and longevity-focused early adopters are often drawn to marine collagen because of its inclusion in 'stacked' wellness protocols. These consumers are constantly researching ingredients that support cellular health, structural proteins, and graceful aging — and they tend to prefer formats that are easy to integrate into repeatable daily cycles. Skincare-first consumers — particularly those building out multi-step regimens — are turning to internal supplements like collagen to complement their topical routines. For these users, the appeal lies in enhancing skin texture, bounce, and hydration by supporting deeper structural layers over time. Consistency is everything, which is why gummy delivery is favored for ease and habit formation. Wellness lifestyle seekers, often in their 30s to 50s, are focused on maintaining energy, appearance, and movement without introducing drastic changes to their routines. These individuals tend to favor non-invasive solutions — ones that feel like a natural part of their morning or evening ritual, not a medical intervention. Active adults and fitness-conscious individuals are another growing segment. These users explore collagen supplementation as part of their joint-support strategy, especially if they're already following clean eating and workout protocols that emphasize recovery and longevity. Lastly, first-time supplement users looking for a gentle introduction to functional beauty routines often choose gummies as a low-friction entry point. The flavor, format, and simplified dosing make collagen supplementation feel more like self-care than medicine — which increases the likelihood of long-term habit adoption. In each case, it's not just about what a supplement does — it's about how easily it fits into a lifestyle built around sustainability, wellness, and proactive aging. Spiritual Optimization & Collagen Curiosity – 2025 Market Reflections The wellness industry in 2025 is evolving beyond traditional health categories. As consumers become more self-aware and future-oriented, a new area of interest is emerging — often described as 'spiritual optimization' or 'conscious wellness.' While still rooted in physical health, this movement explores how daily rituals contribute to emotional clarity, balance, and long-term vitality. Within this context, collagen supplementation has quietly entered the conversation — not as a spiritual tool, but as part of a broader desire for alignment between internal health and external presence. Individuals seeking routines that support calm, glow, and groundedness often turn to products that feel intentional, clean, and self-honoring. Pilly Labs Collagen Gummies are not marketed as spiritual products, but their design reflects many of the values embraced by this consumer segment: natural sourcing, simplicity, and ease of integration into meaningful rituals. Whether it's part of a morning meditation, a skincare wind-down, or a 6AM cold plunge routine, the daily gummy becomes a tactile anchor for self-investment — a micro-commitment to long-term care. This rising interest in 'functional clarity' — where beauty, mood, and longevity intersect — is fueling growth in clean-label, habit-focused supplements that avoid synthetic compounds or hard-sell marketing. Collagen is increasingly seen not just as a cosmetic support, but as part of a lifestyle rooted in maintenance, not repair. Importantly, this reflection is not tied to any belief system or metaphysical claim. Instead, it mirrors a cultural shift toward ritualizing wellness, where collagen fits naturally alongside journaling, hydration tracking, and screen-time reduction. Consumers want support that's subtle, structural, and sustainable — not flashy or overstated. Learn More About Pilly Labs' Marine Collagen Approach The Public Debate Around Collagen – Signals, Skepticism, and Saturation As collagen continues to gain traction in the wellness and beauty space, so too has public discourse evolved. In 2025, the conversation around collagen supplementation isn't just about benefits — it's also about evidence, overexposure, and what counts as meaningful results. Pilly Labs Collagen Gummies enter this landscape at a moment when consumers are asking better questions and expecting more transparency. Positive Signals:Some view the widespread adoption of collagen as a sign that consumers are becoming more proactive about aging, structure, and long-term wellness. This group sees collagen not as a magic bullet, but as a consistent, foundational element of functional health — the same way protein or hydration has become essential to daily maintenance. Supporters often highlight the importance of delivery format, ingredient sourcing, and duration of use when evaluating results, with many leaning toward marine collagen due to its bioavailability and sustainability profile. Skeptical Voices:Others raise valid concerns about whether collagen supplementation lives up to its growing list of perceived benefits. Common points of contention include whether externally sourced collagen can significantly impact internal regeneration, whether brands are overstating cosmetic outcomes, or whether differences between marine, bovine, and porcine types actually matter. This segment of the conversation often calls for more third-party verification, longer clinical timelines, and consumer protections around exaggerated marketing. Neutral Observers:A third perspective — increasingly common among health-savvy consumers — is one of measured experimentation. These users don't expect overnight transformation. Instead, they test products for 3 to 6 months, track skin hydration, joint comfort, and hair resilience, and make purchasing decisions based on real-world fit. They are less influenced by influencer marketing and more aligned with community discussion, reviews, and ingredient transparency. For this group, collagen is one small part of a broader health optimization plan. In a saturated market, credibility comes from clarity — and brands that acknowledge all sides of the debate while maintaining honest, educational messaging tend to earn the most long-term trust. About Pilly Labs Pilly Labs is part of a new generation of wellness companies that prioritize clean beauty, transparency, and long-term health habits over hype. Founded with the belief that better routines begin with better ingredients, the company creates products that support structural wellness — without cutting corners on sourcing, science, or sustainability. The brand's mission is simple: to make foundational health support more accessible, enjoyable, and effective for people seeking internal balance and external confidence. With an ingredient-first philosophy, Pilly Labs formulates each supplement to reflect current research, real consumer needs, and modern preferences for ease, taste, and trust. Pilly Labs Collagen Gummies are a direct result of that philosophy. Each gummy is formulated with hydrolyzed marine collagen peptides, combined with nutrient cofactors like Vitamin C, Biotin, Zinc, and Vitamin E — all frequently discussed in wellness communities for their potential to support skin structure, hair health, and mobility from within. But it's not just about what's inside. Pilly Labs pays close attention to what's excluded, too. The gummies are free from gluten, artificial sweeteners, antibiotics, and synthetic dyes. Even the color and flavor come from natural sources like purple carrot juice concentrate and citrus oils — a nod to the company's broader clean beauty commitment. Rather than chasing fads or flashy claims, Pilly Labs focuses on consistency, education, and sustainability. The goal isn't to promise instant results — it's to help people build simple, effective routines they can stick with for months or years to come. By making high-quality collagen accessible through a convenient gummy format, the company empowers users to take ownership of their beauty and wellness journey with confidence. Tired of powders and pills that disrupt your routine or taste artificial?Try the Collagen Gummy That's Designed for Simplicity and Results Contact Pilly Labs Email Support: info@ Website: Final Disclaimer This press release is for informational purposes only. The information contained herein does not constitute medical advice, diagnosis, or treatment and has not been evaluated by the Food and Drug Administration (FDA). Collagen Supplement is not intended to diagnose, treat, cure, or prevent any disease. Always consult your physician or qualified healthcare provider before beginning any new supplement, routine, or health program. Some links in this release may be promotional in nature and may lead to third-party websites. The publisher or author may receive compensation through affiliate commissions if a purchase is made through these links. This compensation does not affect the price you pay and helps support continued research and content publication. Results described or implied may not be typical and should not be interpreted as guarantees. Statements made about ingredients or outcomes reflect public discussion and historical usage only, and are not endorsed by medical professionals or regulatory agencies. Always do your own research and make informed decisions. CONTACT: Email Support: info@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
an hour ago
- Business Wire
RCKT Deadline: Rosen Law Firm Urges Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action lawsuit on behalf of purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between September 17, 2024 and May 26, 2025. Rocket Pharmaceuticals is a fully integrated, late-stage biotechnology company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Misled Investors Regarding its Business Operations. According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) RP-A501 was less effective than defendants had led investors to believe; (2) to increase its effectiveness, Rocket Pharmaceuticals amended RP-A501's clinical trial protocol by introducing a novel immunomodulatory agent; (3) the foregoing increased the risk that patients would suffer from a Serious Adverse Event ('SAE'); (4) accordingly, RP-A501's safety, as well as its clinical, regulatory, and commercial prospects, were overstated; and (5) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. What Now: You may be eligible to participate in the class action against Rocket Pharmaceuticals, Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by August 11, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome.
